Clinic for psychiatry Sveti Ivan
- Address
- lock Available on a paid plan
Nervous System Diseases
The clinic is advancing research on neuro‑degenerative conditions, aiming to improve safety and symptom control for patients with Alzheimer’s disease‑related complications.
- Agitation associated with Alzheimer’s dementia
- Psychosis linked to Alzheimer’s disease
- Cognitive impairment in schizophrenia
Ongoing studies evaluate new agents for long‑term tolerability and reduction of disruptive behaviors, supporting better quality of life for affected individuals.
Behavioral Disciplines and Activities
Investigations target acute mood disturbances, testing innovative treatments to stabilize severe episodes in bipolar I disorder.
- Manic episodes and mixed features
- Adjunctive therapies for mood stabilization
- Long‑term safety of monotherapy or add‑on regimens
The goal is to provide faster relief of mania while confirming that new medications remain safe during extended use.
Mental Disorders
Research at the site focuses on core psychiatric illnesses, seeking more effective options for patients who do not respond to standard care.
- Schizophrenia and treatment‑resistant schizophrenia
- Major depressive disorder
- Adjunctive treatments to enhance antidepressant response
Trials assess symptom reduction, functional improvement, and long‑term tolerability of novel compounds in these challenging conditions.
Psychological Phenomena
The clinic examines underlying psychological symptoms such as agitation, psychosis, and depressive states, aiming to refine therapeutic strategies.
- Agitation in dementia
- Psychotic symptoms across disorders
- Depressive symptomatology in major depression
By measuring changes in validated rating scales, researchers hope to demonstrate meaningful clinical benefits for patients experiencing these phenomena.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinic for psychiatry Sveti Ivan
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Bioavailability Study of TV-44749 Versus Oral Olanzapine in Schizophrenia Patients | Teva Branded Pharmaceutical Products R&D LLC | Phase I | Not Yet Recruiting | Jun 2024 | Aug 2025 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 4 | Unknown | 2024-05-09 | 2025-09-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.